2020 Annual Meeting | C230 - Clinical Epilepsy 3: Advanced (Status, Beyond AED, Video EEG)

Date Thursday 04/30/20

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) William O. Tatum IV, DO, FAAN

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives Participants should become familiar with patients with uncontrolled seizures and be able to efficiently and thoroughly evaluate people who present with drug-resistance or seizure emergencies and accurately apply concepts from case presentations using ILAE terminology and classification system for epilepsy; choose appropriate first-line treatments; and recognize and know how to evaluate common case scenarios.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Advanced

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
01:00 PM - 01:30 PM	Speaker	Beyond Antiseizure Drugs Elson L. So, MD, FAAN
01:30 PM - 02:00 PM	Speaker	Advanced Approach to Status Epilepticus Frank W. Drislane, MD, FAAN
02:00 PM - 02:30 PM	Speaker	Video-EEG Monitoring in Epilepsy William O. Tatum IV, DO, FAAN
02:30 PM - 02:45 PM	Speaker	Pediatric Advanced Practice Sudha Kessler, MD
02:45 PM - 03:00 PM	Discussion	Panel Discussion

Faculty Disclosures
William O. Tatum IV, DO, FAAN	Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a AAN Section Chair of Clinical Neurophysiology with AAN that is relevant to AAN interests or activities.
Elson L. So, MD, FAAN	Dr. So has nothing to disclose.
Sudha Kessler, MD	Dr. Kessler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Efficient CME. Dr. Kessler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda Pharmaceuticals. The institution of Dr. Kessler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for The Epilepsy Study Consortium. Dr. Kessler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharmaceuticals. Dr. Kessler has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Wilson, Elser. The institution of Dr. Kessler has received research support from FDA, Commonwealth of Pennsylvania, Epilepsy Study Consortium, UCB Pharma, Greenwich Biosciences, Eisai Co. Ltd.. PCORI/AHRQ, SK Life. Dr. Kessler has a non-compensated relationship as a volunteer committee member with American Epilepsy Society that is relevant to AAN interests or activities. Dr. Kessler has a non-compensated relationship as a committee member with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities.
Frank W. Drislane, MD, FAAN	No disclosure on file

��ɫ��

��ɫ��